The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Bolt Biotherapeutics, Inc(NASDAQ:BOLT) 
Bolt Biotherapeutics, Inc., a clinical-stage immuno-oncology company, engages in the discovery, development, and commercialization of pharmaceutical products. The company develops BDC-1001, a human epidermal growth factor receptor 2 (HER2) for the treatment of patients with HER2-expressing solid tum...
Share this website to your friends
Bolt Biotherapeutics Days Payable Outstanding ttm (DPO)
Bolt Biotherapeutics Days Receivable Outstanding ttm (DSO)
Bolt Biotherapeutics Days Inventory Outstanding ttm (DIO)
Bolt Biotherapeutics Op Cashflow Per Share ttm
Bolt Biotherapeutics Free Cashflow Per Share ttm
Bolt Biotherapeutics Cash Per Share ttm
Bolt Biotherapeutics P/S ratio ttm
Bolt Biotherapeutics (GAAP) P/E ratio ttm
Bolt Biotherapeutics P/B ratio ttm
No extra charts and metrics for this ticker.